Диссертация (1140941), страница 15
Текст из файла (страница 15)
Den Boer JA, Bosker FJ & Meesters Y (2006) Clinical efficacy of agomelatine indepression: the evidence. Int Clin Psychopharmacol 21 (Suppl. 1), S21–S24.63. Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ & Deng MH (1994) Effect of inducingnocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature,and performance. Proc Natl Acad Sci USA 91, 1824–1828.64. Dubocovich ML, Cardinali DP, Delagrange P, Krause DN, Strosberg D, Sugden D &Yocca FD (2000) Melatonin receptors. In The IUPHAR Compendium of ReceptorCharacterization and Classification, 2nd edn.
(IUPHAR, ed.), pp. 271–277. IUPHARMedia, London.65. Dubocovich ML & Markowska M (2005) Functional MT1 and MT2 melatonin receptorsin mammals. Endocrine 27, 101–110.66. El-Shenawy SM, Abdel-Salam OM, Baiuomy AR, El-Batran S, Arbid MS, Studies on theanti-inflammatory and anti-nociceptive effects of melatonin in the rat. Pharmacol Res.2002;46(3):235-243.9767.
Esposito E, Paterniti I, Mazzon E, Bramanti P, Cuzzocrea S. Melatonin reduceshyperalgesia associated with inflammation. J Pineal Res. 2010;49(4):321-331.68. Fahn S & Cohen G (1992) The oxidant stress hypothesis in Parkinson’s disease: evidencesupporting it. Ann Neurol 32, 804–812.69. Fairbank JCT & Pynsent, Oswestry Low Back Pain Disability Questionnaire Sources:,The Oswestry Disability Index.
Spine, 2000, 25(22):2940-2953.70. Feng Z, Chang Y, Cheng Y, Zhang BL, Qu ZW, Qin C & Zhang JT (2004) Melatoninalleviates behavioral deficits associated with apoptosis and cholinergic system dysfunctionin the APP 695 transgenic mouse model of Alzheimer’s disease. J Pineal Res 37, 129–136.71. Ferry G, Ubeaud C, Lambert PH, Bertin S, Coge F, Chomarat P, Delagrange P, Serkiz B,Bouchet JP, Truscott RJ et al. (2005) Molecular evidence that melatonin is enzymaticallyoxidized in a different manner than tryptophan.
Investigation on both indoleamine-2,3dioxygenase and myeloperoxidase. Biochem J 388, 205–215.72. FreynhagenR1, BaronR, GockelU, TölleTR.РainDETECT:anewscreening questionnaire to identify neuropathic components in patients with back pain.Curr Med Res Opin. 2006 Oct;22(10):1911-20.73. Garcia-Maurino S, Pozo D, Carrillo-Vico A, Calvo JR & Guerrero JM (1999) Melatoninactivates Th1 lymphocytes by increasing IL-12 production. Life Sci 65, 2143–2150.74. Gerdin MJ, Masana MI, Rivera-Bermudez MA, Hudson RL, Earnest DJ, Gillette MU &Dubocovich ML (2004) Melatonin desensitizes endogenous MT2 melatonin receptors inthe rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of themammalian circadian clock to melatonin.
FASEB J 18, 1646–1656.75. Gilad E, Laufer M, Matzkin H & Zisapel N (1999) Melatonin receptors in PC3 humanprostate tumor cells. J Pineal Res 26, 211–220.76. Golombek DA, Escolar E, Burin LJ, Bristo-Sanchez MG, Cardinali DP. Time dependentmelatonin analgesia in mice: inhibition by opiate or benzo- diazepine antagonism. Eur JPharmacol. 1991;194:25-30.9877. Govitrapong P, Sawlom S, Ebadi M. The presence of delta and mu-, but not kappa orORL1 receptors in bovine pinealocytes. Brain Research 951 (1), 23–30, 2002.78. Grant S, Aitchison T, Henderson E, Christie J, Zare S, McMurray J, Dargie H.
Acomparison of the reproducibility and the sensitivity to change of visual analogue scales,Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest. 1999Nov;116(5):1208-17.79. Hardeland R & Pandi-Perumal SR (2005) Melatonin, a potent agent in antioxidativedefense: Actions as a natural food constituent, gastrointestinal factor, drug and prodrug.Nutr Metab (Lond) 2, 22.80. Hardeland R, Poeggeler B, Behrmann G & Fuhrberg B (1996) Enzymatic and nonenzymatic metabolism of methoxyindoles. In Metabolism and Cellular Dynamics ofIndoles (Hardeland R, ed.), pp. 6–22. University of Goettingen, Goettingen.81.
Hardeland R, Poeggeler B, Niebergall R & Zelosko V (2003) Oxidation of melatonin bycarbonate radicals and chemiluminescence emitted during pyrrole ring cleavage. J PinealRes 34, 17–25.82. Herxheimer A & Petrie KJ (2002) Melatonin for the prevention and treatment of jet lag.Cochrane Database Syst Rev CD001520.83. Hu DN, McCormick SA & Roberts JE (1998) Effects of melatonin, its precursors andderivatives on the growth of cultured human uveal melanoma cells.
Melanoma Res 8, 205–210.84. Hussain SA, Al-Khalifa II, Jasim NA, Gorial FI. Adjuvant use of melatonin for treatmentof fibromyalgia. J Pineal Res. 2011;50:267-271.85. Kanishi Y, Kobayashi Y, Noda S, Ishizuka B & Saito K (2000) Differential growthinhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res 28, 227–233.86. Karbownik M, Lewinski A & Reiter RJ (2001) Anticarcinogenic actions of melatoninwhich involve antioxidative processes: comparison with other antioxidants. Int J BiochemCell Biol 33, 735–753.9987. Karolczak M, Korf HW & Stehle JH (2005) The rhythm and blues of gene expression inthe rodent pineal gland. Endocrine 27, 89–100.88. Kayumov L, Brown G, Jindal R, Buttoo K & Shapiro CM (2001) A randomized, doubleblind, placebo-controlled crossover study of the effect of exogenous melatonin on delayedsleep phase syndrome.
Psychosom Med 63, 40–48.89.Klerman EB, Goldenberg DL, Brown EN, Maliszewski AM, Adler GK. Circadian rhythmsof women with fibromyalgia. J Clin Endocrinol Metab. 2001;86:1034-1039.90. LacosteB, AngeloniD, Dominguez-LopezS, CalderoniS, MauroA, FraschiniF, Descarries L, Gobbi G. Anatomical and cellular localization of melatonin MT1 andMT2 receptors in the adult rat brain. J Pineal Res. 2015 May;58(4):397-417.91.Lakin ML, Miller CH, Stott ML, Winters WD.
Involvement of the pineal gland andmelatonin in murine analgesia. Life Sciences 29 (24), 2543–2551, 1981.92.Leone M, D’Amico D, Moschiano F et al. Melatonin versus placebo in the prophylaxis ofcluster headache: a double-blind pilot study with parallel groups. Cephalalgia.1996;16:494-496.93.Lewy AJ, Ahmed S, Jackson JM & Sack RL (1992) Melatonin shifts human circadianrhythms according to a phase-response curve. Chronobiol Int 9, 380–392.94.Liu C, Weaver DR, Jin X, Shearman LP, Pieschl RL, Gribkoff VK & Reppert SM (1997)Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadianclock. Neuron 19, 91–102.95.Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, DubocovichML.MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.
Annu Rev PharmacolToxicol. 2016 Jan 6;56:361-83.96.Loo H, Dalery J, Macher JP & Payen A (2002) [Pilot study comparing in blind thetherapeutic effect of two doses of agomelatine, melatoninergic agonist and selective5HT2C receptors antagonist, in the treatment of major depressive disorders]. Encephale 28,356–362.10097. Lopez-CanulS, AngeloniM, PalazzoD, FraschiniE, Dominguez-LopezF, BoccellaS, SpadoniS, LuongoG, BediniL, LacosteB, ComaiA, TarziaG, MaioneS, Granados-Soto V, Gobbi G. Selective melatonin MT2 receptor ligands relieveneuropathic pain through modulation of brainstem descending antinociceptive pathways.Pain.
2015 Feb;156(2):305-17.98. López-Canul M, Comai S, Domínguez-López S, Granados-Soto V, Gobbi G.Antinociceptive properties of selective MT2 melatonin receptor partial agonists. Eur JPharmacol. 2015 Oct 5;764:424-32.99. Lu WZ, Gwee KA, Moochhalla S, Ho KY, Melatonin improves bowel symptoms infemale patients with irritable bowel syndrome: a double-blind placebo-controlled study.Aliment Pharmacol Ther. 2005;22(10):927-934.100.Lutsch EF, Morris RW. Light reversal of a morphine-induced analgesiasusceptibility rhythm in mice. Experientia 27 (6), 420–421, 1971.101.Macchi MM & Bruce JN (2004) Human pineal physiology and functionalsignificance of melatonin. Front Neuroendocrinol 25, 177–195.102.Mahlberg R, Kunz D, Sutej I, Kuhl KP & Hellweg R (2004) Melatonin treatment ofday-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilotstudy using actigraphy.
J Clin Psychopharmacol 24, 456–459.103.Maestroni GJ, Conti A & Pierpaoli W (1986) Role of the pineal gland in immunity.Circadian synthesis and release of melatonin modulates the antibody response andantagonizes the immunosuppressive effect of corticosterone. J Neuroimmunol 13, 19–30.104.Maestroni GJM, Cardinali DP, Esquifino AI & Pandi- Perumal SR (2004) Doesmelatonin play a disease-promoting role in rheumatoid arthritis? J Neuroimmunol 158,106–111.105.Manev H, Uz T & Qu T (1998) Early upregulation of hippocampal 5-lipoxygenasefollowing systemic administration of kainate to rats. Rest Neurol Neurosci 12,81–85.106.Mantovani M1, Pértile R, Calixto JB, Santos AR, Rodrigues AL.
Melatonin exertsan antidepressant-like effect in the tail suspension test in mice: evi- dence for involvement101of N-methyl-D-aspartate receptors and the L-argi- nine-nitric oxide pathway. NeurosciLett. 2003;343(1):1-4.107.Mantovani M, Kaster MP, Pertile R, Calixto JB, Rodriguez AL, Santos AR.Mechanisms involved in the antinociception caused by melatonin in the mice. J Pineal Res.2006;41: 382– 9.108.Martin JB (1999) Molecular basis of the neurodegenerative disorders. N Engl J Med340, 1970–1980.109.Martin Roland and Jeremy Fairbank. The Roland–Morris Disability Questionnaireand the Oswestry Disability Questionnaire, SPINE Volume 25, Number 24, pp 3115–3124, 2000.110.Masruha MR, de Sousa Vieira DS, Minett TS et al. Low urinary 6-sulphatoxymelatonin concentrations in acute migraine.
J Headache Pain 2008; 9:221–224.111.Mayo, J.C., Sainz, R.M., Tan, D.X., et al. (2005) Anti-Inflammatory Actions ofMelatonin and Its Metabolites, N1-Acetyl-N2-formyl-5-methoxykynuramine (AFMK) andN1-Acetyl-5-methoxykynuramine (AMK), in Macrophages. Journal of Neuroimmunology,165, 139-149.112.Miano S, Parisi P, Pellicci A, Luchetti A, Paolino MCh, Villa MP. Melato- nin toprevent migraine or tension-type headache in children.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
